Literature DB >> 15531031

Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes.

Holger Bartz1, Yuri Mendoza, Miriam Gebker, Till Fischborn, Klaus Heeg, Alexander Dalpke.   

Abstract

CpG-oligonucleotides (CpG-ODN) have been shown to exert strong immuno-stimulatory effects through activation of Toll-like receptor 9 (TLR-9). However, TLR-9 triggering takes place in endosomal compartments and thus CpG-ODN have to be taken up prior to signal transduction. We here report that 3'-poly-guanosine strings can improve cellular internalisation of phosphodiester but not of phosphorothioate CpG-ODN. Improved cellular uptake correlated with enhanced IL-6 secretion and proliferation of PBMC. Also, TLR-9 transfected HEK293 cells were activated more efficiently by poly-guanosine modified CpG-ODN. The results indicate that the synthesis of stimulatory CpG-ODN based on a phosphodiester backbone is feasible via such poly-guanosine substitutions. In addition we observed that phosphorothioate ODN were able to exert immunostimulatory effects independent of the presence of CpG motifs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531031     DOI: 10.1016/j.vaccine.2004.05.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

2.  B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids.

Authors:  Munir Akkaya; Billur Akkaya; Pietro Miozzo; Mukul Rawat; Mirna Pena; Patrick W Sheehan; Ann S Kim; Olena Kamenyeva; Juraj Kabat; Silvia Bolland; Akanksha Chaturvedi; Susan K Pierce
Journal:  J Immunol       Date:  2017-06-26       Impact factor: 5.422

3.  A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpG-motif in human B cells and primary peripheral blood mononuclear cells.

Authors:  Miriam Mende; Anne Hopert; Winfried Wünsche; Marita Overhoff; Anke Detzer; Kirsten Börngen; Peter Schlenke; Holger Kirchner; Georg Sczakiel
Journal:  Immunology       Date:  2006-11-27       Impact factor: 7.397

4.  Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands.

Authors:  Nicole Fitzner; Sigrid Clauberg; Frank Essmann; Joerg Liebmann; Victoria Kolb-Bachofen
Journal:  Clin Vaccine Immunol       Date:  2007-10-31

5.  Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.

Authors:  Fabrice Cognasse; Hind Hamzeh-Cognasse; Sandrine Lafarge; Patricia Chavarin; Bruno Pozzetto; Yolande Richard; Olivier Garraud
Journal:  Immunology       Date:  2008-04-28       Impact factor: 7.397

6.  Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B4 receptors.

Authors:  Charlotte Admyre; Lars-Göran Axelsson; Oliver von Stein; Arezou Zargari
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

7.  Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.

Authors:  Wenjun Meng; Tomohiko Yamazaki; Yuuki Nishida; Nobutaka Hanagata
Journal:  BMC Biotechnol       Date:  2011-09-26       Impact factor: 2.563

8.  Conditional immortalization of human B cells by CD40 ligation.

Authors:  Martina Wiesner; Caroline Zentz; Christine Mayr; Rainer Wimmer; Wolfgang Hammerschmidt; Reinhard Zeidler; Andreas Moosmann
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

9.  Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates.

Authors:  Montserrat Puig; Andrzej Grajkowski; Malgorzata Boczkowska; Cristina Ausín; Serge L Beaucage; Daniela Verthelyi
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

10.  Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.

Authors:  Taiki Aoshi; Yasunari Haseda; Kouji Kobiyama; Hirotaka Narita; Hideaki Sato; Hirokazu Nankai; Shinichi Mochizuki; Kazuo Sakurai; Yuko Katakai; Yasuhiro Yasutomi; Etsushi Kuroda; Cevayir Coban; Ken J Ishii
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.